Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
about
Pediatric neuroendocrine carcinoid tumors: Management, pathology, and imaging findings in a pediatric referral center.Optimization of liposomal topotecan for use in treating neuroblastoma.Hepatic metastatic disease in pediatric and adolescent solid tumors.Androgen Receptor Regulates the Growth of Neuroblastoma Cells in vitro and in vivoNeuroendocrine cancer vaccines in clinical trials.Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.Molecular imaging of adrenal neoplasms.WHO Grade 2 Neuroendocrine Tumor in a 15-Year-Old Male: A Case Report and Literature ReviewmiR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth.Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells.Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy.A 17-year-old male with a Small Bowel Neuroendocrine Tumor: flushing differential diagnosis.Safety and accuracy of 68Ga-DOTATOC PET/CT in children and young adults with solid tumors.
P2860
Q30274755-E29C4AAC-750D-47A9-8B07-F9746750FF3DQ33775276-4A2557BE-BEE7-4884-A6D0-5A487ABFBDF6Q35864811-D8DA8D24-FE96-4A2E-B04F-8B8F48BD61A9Q37683259-D72BF739-16E2-4189-960E-84E9D52486CCQ37892589-D86020C0-EAE5-460E-990F-65F7E2AAE87AQ37939996-F2956D5C-2FDF-4808-8FF0-5A4E2BA34E8FQ38013072-13358630-6A89-4DC1-95BC-CC04CCD19784Q38294469-EF9719CA-A7AA-4E60-8CE4-DCF2E0E0DC13Q39076744-04005531-E084-453B-A2BC-9A562A7A4724Q39188198-DDFA2FA1-36ED-4893-8771-F4691AD2A2FCQ39450337-C20F29CA-A736-4301-81DC-DACFBDA97DC4Q40449073-77FE4858-30A1-4C74-AC22-F755F22A1C47Q41600928-1FAC8932-E754-475F-AD13-BE96F7058A3AQ47155891-B74AA43C-139F-448E-BC34-8CDF469710B2
P2860
Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@ast
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@en
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@nl
type
label
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@ast
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@en
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@nl
prefLabel
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@ast
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@en
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@nl
P2093
P2860
P50
P356
P1476
Incidence, survival, and preva ...... rd SEER registries, 1975-2006.
@en
P2093
Charles F Lynch
Gideon K D Zamba
Pournima Navalkele
P2860
P356
10.1002/PBC.22559
P577
2011-01-01T00:00:00Z